The "Journal of Cancer Research and Clinical Oncology" publishes significant and up-to-date articles within the fields of experimental and clinical oncology. The journal, which is chiefly devoted to Original papers, also includes Reviews as well as Editorials and Guest editorials on current, controversial topics. The section Letters to the editors provides a forum for a rapid exchange of comments and information concerning previously published papers and topics of current interest. Meeting reports provide current information on the latest results presented at important congresses. The following fields are covered: carcinogenesis - etiology, mechanisms; molecular biology; recent developments in tumor therapy; general diagnosis; laboratory diagnosis; diagnostic and experimental pathology; oncologic surgery; and epidemiology.
Journal of Cancer Research and Clinical Oncology
Description
Identifiers
ISSN | 0171-5216 |
e-ISSN | 1432-1335 |
DOI | 10.1007/432.1432-1335 |
Publisher
Springer Berlin Heidelberg
Additional information
Data set: Springer
Articles
Journal of Cancer Research and Clinical Oncology > 2019 > 145 > 12 > 3115-3123
Purpose It is well documented that patients with Beckwith–Wiedemann spectrum (BWS) have a significantly higher risk of developing Wilms tumor (WT) than the general population. There has been little research on the timing of WT diagnosis in BWS in regard to optimizing suggested screening protocols. Methods A literature search was performed to identify all reports of patients with BWS and WT. These...
Journal of Cancer Research and Clinical Oncology > 2019 > 145 > 12 > 3067-3073
Background The combination of dexamethasone, high-dose cytarabine, and cisplatin (DHAP) is an established salvage regimen for lymphoma patients. We hypothesized that a modified administration schedule for cisplatin and cytarabine results in lower toxicity and improved efficacy. Methods We retrospectively analysed 119 patients with relapsed or refractory, aggressive, or indolent B-cell lymphomas,...